Medical Procedures on TRT – 12 Rules to Live by on Testosterone

Member Access Required

Already a member? Sign In

Timeline

00:00

Rule five introduces how medical procedures fit into safer testosterone decision making. A systems framework is promised so patients know when tests are appropriate.

01:27

Central nervous system evaluation is reviewed, including when a brain MRI becomes reasonable. Pituitary and hypothalamus questions are connected to understanding low testosterone drivers.

05:00

Persistently elevated prolactin is discussed as a clue that sometimes justifies pituitary imaging. Rare prolactinoma findings are mentioned alongside medical management using carbergiline.

06:41

Gynecomastia with an unusual mass triggers discussion about breast cancer vigilance in men. Mammogram, ultrasound, and biopsy are described as procedures that clarify malignancy risk.

08:41

Cardiovascular history is framed as essential before ordering specialized heart testing. Coronary calcium scoring is discussed as a selective tool for higher risk individuals.

12:14

Echocardiogram and stress testing are presented as cardiology level procedures for specific cases. Testing is tied to hypertension, lipid history, and established heart disease concerns.

15:52

Testicular atrophy and fertility effects are acknowledged during long term androgen exposure. Ultrasound is described as a urology directed procedure when cancer risk is suspected.

18:23

Prostate monitoring is reviewed as a separate topic guided by urologists and clear protocols. PSA testing and digital rectal examination are emphasized as procedure based vigilance steps.

23:33

Closing remarks encourage individualized screening instead of one size fits all checklists. Shared decisions with specialists are framed as the safest way to continue therapy.

Video Summary

Medical procedures are discussed as rule five within a broader testosterone safety framework. A systems approach is used to decide which evaluations make sense before starting therapy. Central nervous system workup is framed as uncommon, yet sometimes appropriate for select symptoms. Brain MRI is mentioned for assessing hypothalamus and pituitary drivers of low testosterone. Persistently elevated prolactin is described as a reason to consider pituitary imaging. Incidental prolactinoma findings are discussed as rare but clinically meaningful for libido concerns. Medical management with carbergiline is mentioned as an option when surgery is not pursued.

Breast and chest evaluation is reviewed when gynecomastia includes a concerning lump or asymmetry. Breast cancer is described as uncommon in men, yet vigilance is still recommended. Testosterone and steroids are stated as not being implicated in causing breast cancer directly. Imaging options are listed, including mammogram, ultrasound, and sometimes breast MRI. A biopsy is presented as the definitive next step when malignancy cannot be ruled out. Clinical judgment is emphasized, including careful history and focused physical examination. Referral to appropriate surgeons and specialists is encouraged when uncertainty remains.

Cardiovascular procedures are discussed because heart disease remains a leading cause of death. Risk stratification is tied to age, hypertension history, and long standing lipid problems. Coronary calcium scoring is presented as a practical radiology study for selected higher risk men. Echocardiography and stress testing are described as cardiology directed tools for targeted situations. Urology procedures are reviewed, including testicular ultrasound when cancer risk is considered. Testicular atrophy and fertility effects are acknowledged as expected changes during androgen use. Prostate vigilance is discussed with PSA testing and digital rectal examination guided by urologists.

Drug Callouts

Testosterone

Testosterone is an androgen hormone prescribed for hypogonadism and monitored with periodic evaluations. The discussion frames testosterone as the context for deciding which procedures are appropriate.

Carbergiline

Carbergiline is mentioned as a medication used to manage prolactin related pituitary issues. The episode references carbergiline while describing rare prolactinoma findings during evaluation.

Condition Callouts

Prolactinoma

Prolactinoma is a pituitary tumor that raises prolactin and can disrupt sexual function. Rare prolactinoma findings are discussed after elevated prolactin prompts brain MRI consideration.

Gynecomastia

Gynecomastia is benign enlargement of male breast tissue that can form palpable lumps. The discussion focuses on evaluating gynecomastia when a mass seems atypical or unilateral.

Breast cancer

Breast cancer is malignant growth in breast tissue and occurs far less often in men. Breast cancer vigilance is described when concerning breast masses require imaging and biopsy.

Testicular cancer

Testicular cancer is a malignancy of the testes that most often affects younger adult men. Ultrasound is described as a urology procedure when testicular cancer risk must be excluded.

Prostate cancer

Prostate cancer is malignant growth in prostate tissue that can progress if untreated. Prostate cancer is discussed while emphasizing PSA monitoring and urologist guided examinations.

Hypogonadism

Hypogonadism is inadequate testosterone production causing symptoms and abnormal laboratory results. The episode frames hypogonadism evaluation as the reason procedures and labs may be ordered.

Hypertension

Hypertension is persistently elevated blood pressure that damages vessels and increases cardiac risk. Hypertension history is used to decide when advanced cardiovascular testing becomes reasonable.

Coronary artery disease

Coronary artery disease is plaque buildup in heart arteries that can cause heart attacks. Coronary risk discussion includes calcium scoring and cardiology directed stress testing procedures.

Hyperlipidemia

Hyperlipidemia is elevated cholesterol or triglycerides that increases atherosclerosis and cardiovascular risk. Lipid problems are referenced while explaining who should receive additional heart evaluations.

Key Takeaways

Procedures are framed as a systems approach to safer testosterone related medical care.
Brain MRI is discussed for select cases with elevated prolactin and pituitary concern.
Gynecomastia evaluation may include mammogram, ultrasound, and biopsy when needed.
Cardiovascular testing is tailored using age, hypertension, and lipid risk factors.
Urology procedures include testicular ultrasound and prostate screening with PSA protocols.